To this end, BM mononuclear cells (BM-MNCs), containing tumor cells, autologous effector cells, and immune suppressive cells, were incubated for 48 h with 10 μg/mL daratumumab, after which MM cell survival was determined by enumeration of viable CD138+ cells by flow cytometric analysis. The gene discussed is SDC1; the disease is Miyoshi myopathy.